Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-19

Clinical Trial Update: Nasal Decongestant to Reduce Perioperative Adverse Events in Children With Upper Respiratory Track Infections Having Anesthesia. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial sponsored by Telethon Kids Institute is evaluating whether a nasal decongestant can reduce perioperative respiratory adverse events in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nasal decongestant (unspecified)

Snippet

Sponsor: Telethon Kids Institute | Conditions: Perioperative Respiratory Adverse Events, Anesthesia Outcomes | Phase 4 | Status: RECRUITING